The Study to Explore Early Development (SEED) - Phase 3 (Modified for COVID-19 Impact Assessment)

OMB 0920-1171

OMB 0920-1171

SEED is a multi-state case-control study designed to investigate risk factors for Autism Spectrum Disorders (ASDs) and the health and behavioral characteristics of children with ADS. SEED is specifically designed focused on preconception, prenatal, perinatal and early postnatal risk factors with primary emphasis on genetic, infectious, immunological, hormonal, and obstetric risk factors. Due to COVID-19, remote administration and feedback is being proposed in this change request.

The latest form for The Study to Explore Early Development (SEED) - Phase 3 (Modified for COVID-19 Impact Assessment) expires 2021-12-31 and can be found here.

Latest Forms, Documents, and Supporting Material
Document
Name
Form
Form and Instruction
Form and Instruction
Supplementary Document
Supplementary Document
Supplementary Document
Justification for No Material/Nonsubstantive Change
Supplementary Document
Supplementary Document
Supplementary Document
Justification for No Material/Nonsubstantive Change
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supplementary Document
Supporting Statement B
Supporting Statement A
OMB Details

ASD - PRE-ENROLLMENT_Invitation Packet/Response Card (Mother)

Federal Enterprise Architecture: Health - Public Health Monitoring


© 2021 OMB.report | Privacy Policy